Vascular Function and Blood Pressure Regulation

Endothelial and Smooth Muscle Regulation

The vascular endothelium is not merely a lining; it is a dynamic organ that maintains homeostasis by regulating vascular tone, platelet clotting, inflammation, hormone metabolism, and smooth-muscle growth.

Endothelial Homeostasis

Vascular tone is a delicate balance between vasodilators and vasoconstrictors. For example, Nitric Oxide (NO) promotes vasodilation, while Endothelin causes vasoconstriction. Endothelial dysfunction occurs when this balance shifts toward a pro-constrictive and pro-inflammatory state.

One critical pathway for relaxation is the eNOS–NO–sGC–cGMP–PKG pathway:

1. L-arginine is converted to NO by endothelial nitric oxide synthase (eNOS).
2. NO diffuses into vascular smooth muscle and activates soluble guanylyl cyclase (sGC).
3. sGC converts GTP to cGMP.
4. cGMP activates Protein Kinase G (PKG), which decreases intracellular $Ca^{2+}$ and increases Myosin Light Chain Phosphatase (MLCP) activity.
5. This results in myosin-light-chain dephosphorylation and subsequent relaxation.

Smooth Muscle Contraction Mechanics

The diameter of a vessel is determined by the contraction or relaxation of the smooth muscle in the tunica media.

• Contraction (Vasoconstriction): An increase in intracellular $Ca^{2+}$ causes $Ca^{2+}$ to bind to calmodulin. This complex activates Myosin Light Chain Kinase (MLCK), which phosphorylates the myosin light chain, triggering actin-myosin cycling and contraction. This decreases the lumen radius, increases resistance, and decreases local blood flow.
• Relaxation (Vasodilation): A decrease in $Ca^{2+}$ leads to decreased MLCK activity and increased MLCP activity, resulting in dephosphorylation and relaxation. This increases the lumen radius, decreases resistance, and increases local blood flow.

Exam Tip: Receptor Signaling Pay close attention to the G-protein coupling of cardiovascular receptors:

• $\alpha_1$: $G_q$ protein $\rightarrow$ $IP_3/DAG$ $\rightarrow$ Vasoconstriction.
• $\alpha_2$: $G_i$ protein $\rightarrow$ $\downarrow$ cAMP.
• $\beta_1$: $G_s$ protein $\rightarrow$ $\uparrow$ cAMP $\rightarrow$ $\uparrow$ Heart Rate/Contractility.
• $\beta_2$: $G_s$ protein $\rightarrow$ $\uparrow$ cAMP $\rightarrow$ Vasodilation.
• $M_2$: $G_i$ protein $\rightarrow$ $\downarrow$ Heart Rate.
• $M_3$: $G_q$ protein $\rightarrow$ Vasoconstriction.

Hemodynamics and Blood Pressure Regulation

Blood pressure (BP) is the force exerted by blood against vessel walls. It is defined by three key metrics:

• Systolic BP: The highest pressure during ventricular contraction.
• Diastolic BP: The lowest pressure during ventricular relaxation.
• Mean Arterial Pressure (MAP): The average pressure throughout the cardiac cycle.

The relationship between these variables is expressed by the following equations: $MAP \approx DBP + \frac{1}{3}(SBP - DBP)$ $MAP \approx CO \times SVR$ Where $CO$ is Cardiac Output and $SVR$ is Systemic Vascular Resistance.

Mechanisms of Control

The body employs three distinct levels of regulation to maintain MAP:

1. Rapid Regulation: The Baroreceptor Reflex

Baroreceptors sense changes in stretch. If BP increases, baroreceptor firing increases, leading to increased parasympathetic activity and decreased sympathetic activity, which lowers HR and contractility to reduce BP. Conversely, a drop in BP (such as when standing up) decreases baroreceptor firing, triggering a sympathetic surge to increase HR, contractility, and vasoconstriction.

Clinical Note: Orthostatic Hypotension When a person stands suddenly, blood can pool in the lower body, reducing venous return, stroke volume (SV), and cardiac output (CO). If the baroreceptor reflex is inadequate, this results in orthostatic hypotension.

2. Long-term Regulation: The RAAS Pathway

The Renin-Angiotensin-Aldosterone System (RAAS) is a critical hormonal cascade for managing blood volume and long-term pressure.

1. Renin Release: Triggered by decreased renal perfusion, decreased $NaCl$ delivery to the macula densa, or increased sympathetic stimulation of $\beta_1$ receptors on juxtaglomerular (JG) cells.
2. Cascade: Renin converts angiotensinogen to Angiotensin I (Ang I), which is then converted to Angiotensin II (Ang II) by ACE.
3. Ang II Actions: Ang II is a potent vasoconstrictor (via $AT_1$ receptors) and stimulates the release of Aldosterone.
4. Aldosterone Actions: Promotes $Na^+$ reabsorption and $K^+$ excretion in the distal nephron, leading to water retention and increased blood volume.

Other hormonal players include ADH (increases water reabsorption) and ANP (promotes natriuresis and vasodilation to lower BP).

Pathophysiology of Hypertension

Hypertension can arise from various hemodynamic imbalances:

• High Cardiac Output: Often driven by increased blood volume or sympathetic activity.
• High SVR: Caused by persistent arteriolar vasoconstriction or vascular remodeling (wall thickening and lumen narrowing).
• Renal/Hormonal: Driven by $Na^+$ retention or excessive Ang II/Aldosterone activity.